Impact of dyslipidemia on the IgM repertoire in atherosclerotic mice

Autor: Deroissart, J., Romanovskaia, D., Derdak, S., Schulte, C., Pölzl, D., Jeitler, M., Göderle, L., Bock, C., Bilban, M., Maric, H.M., Binder, C.J.

Publikováno v: In Atherosclerosis August 2022 355

Deletion of Viperin in the hematopoietic system aggravates atherosclerosis

Autor: Smeets, D., Porsch, F., Goederle, L., Binder, C.J., Tsiantoulas, D.

Publikováno v: In Atherosclerosis August 2022 355

Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis.

Autor: Kiss MG; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. Electronic address: mate.kiss@mssm.edu., Papac-Miličević N; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Porsch F; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Tsiantoulas D; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK., Hendrikx T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Takaoka M; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK., Dinh HQ; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Narzt MS; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Göderle L; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Ozsvár-Kozma M; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Schuster M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Fortelny N; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria., Hladik A; Department of Medicine I, Laboratory of Infection Biology, Medical University of Vienna, Vienna, Austria., Knapp S; Department of Medicine I, Laboratory of Infection Biology, Medical University of Vienna, Vienna, Austria., Gruber F; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Pickering MC; Centre for Inflammatory Disease, Imperial College, London, UK., Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Medical University of Vienna, Institute of Artificial Intelligence, Center for Medical Data Science, Vienna, Austria., Swirski FK; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ley K; Immunology Center of Georgia, Augusta University, Augusta, GA, USA., Zernecke A; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany., Cochain C; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany; Comprehensive Heart Failure Center Würzburg, University Hospital Würzburg, Würzburg, Germany., Kemper C; Inflammation Research Section, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA., Mallat Z; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK; Institut National de la Santé et de la Recherche Médicale, Paris Cardiovascular Research Center, Paris, France., Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. Electronic address: christoph.binder@meduniwien.ac.at.

Publikováno v: Immunity [Immunity] 2023 Aug 08; Vol. 56 (8), pp. 1809-1824.e10. Date of Electronic Publication: 2023 Jul 26.

APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.

Autor: Tsiantoulas D; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. dimitris.tsiantoulas@meduniwien.ac.at., Eslami M; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Obermayer G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Clement M; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK., Smeets D; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Mayer FJ; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Kiss MG; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Enders L; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Weißer J; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Göderle L; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Lambert J; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK., Frommlet F; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria., Mueller A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Hendrikx T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Ozsvar-Kozma M; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Porsch F; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Willen L; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Afonyushkin T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Murphy JE; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK., Fogelstrand P; Institute of Medicine, University of Gothenburg, Göteborg, Sweden., Donzé O; Adipogen Life Sciences, Epalinges, Switzerland., Pasterkamp G; University Medical Center Utrecht, Utrecht, the Netherlands., Hoke M; Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Kubicek S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Jørgensen HF; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK., Danchin N; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Department of Cardiology, Paris, France.; University School of Medicine, Université de Paris, Paris, France., Simon T; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (URCEST-CRB-CRC), Paris, France.; Department of Pharmacology, Sorbonne-Université (UPMC-Paris 06), Paris, France., Scharnagl H; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria., März W; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.; Medical Clinic V, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; SYNLAB Academy, Synlab Holding Deutschland GmbH, Augsburg, Germany., Borén J; Institute of Medicine, University of Gothenburg, Göteborg, Sweden., Hess H; Translational Innovation Platform Immunology, Merck KGaA, Darmstadt, Germany., Mallat Z; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.; Université de Paris and INSERM U970, Paris Cardiovascular Research Center, Paris, France., Schneider P; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. christoph.binder@meduniwien.ac.at.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. christoph.binder@meduniwien.ac.at.

Publikováno v: Nature [Nature] 2021 Sep; Vol. 597 (7874), pp. 92-96. Date of Electronic Publication: 2021 Aug 25.

High expression of PLA2G2A in fibroblasts plays a crucial role in the early progression of carotid atherosclerosis.

Autor: Wang, Xin^1,2 (AUTHOR), Li, Shen^2,3 (AUTHOR), Liu, Chen^1,2 (AUTHOR), Zhao, Jiawei^1,2 (AUTHOR), Ren, Gangfeng^1,3 (AUTHOR), Zhang, Feng^1,3 (AUTHOR), Liu, Xuyang^1,2 (AUTHOR), Cao, Shuang^1,3 (AUTHOR), Xu, Yuming^2,3 (AUTHOR) xuyuming@zzu.edu.cn, Xia, Zongping^1,3 (AUTHOR) zxia2018@zzu.edu.cn

Publikováno v: Journal of Translational Medicine. 10/24/2024, Vol. 22 Issue 1, p1-15. 15p.